dihexa cognitive enhancement 2019 chemically induced 2024 aged Alzheimer's disease drug development pipeline: - Cummings - 2024 - Alzheimer's & Dementia: Translational Research & Clinical Interventions DIHEXA - Beverly Hills Rejuvenation
Description
& Leandersson, K
Flexible Protocols: Daily or every-other-day subcutaneous injections
The standard MOTS-c dosage is 5 to 10 mg per week via subcutaneous injection, administered once or twice weekly, for cycles of 8 to 12 weeks
It also acts as a potent anti-inflammatory, which is why it has been explored as a replacement for corticosteroids in certain inflammatory skin conditions
